Header Logo

Connection

LUCAS WONG to Pancreatic Neoplasms

Back to Details
This is a "connection" page, showing publications LUCAS WONG has written about Pancreatic Neoplasms.
LUCAS WONG
Connection Strength
0.097
Pancreatic Neoplasms
  1. A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-na?ve Pancreatic Adenocarcinoma. Am J Clin Oncol. 2018 03; 41(3):230-235.
    View in: PubMed
    Score: 0.097
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.